美国 · 平台与数据 · Yahoo Finance

Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory ...

来源：Yahoo Finance · 美国 9 小时前

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the…

在 Yahoo Finance 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)

推荐阅读

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

These stocks have soared the most today after the Democrats trounced Trump

Neuronetics (NASDAQ:STIM) Releases Quarterly Earnings Results, Beats Expectations By $0.07 EPS

The Motley Fool

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop